Trials / Completed
CompletedNCT01431508
A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)
An Open-label, Single Arm, Prospective Study to Evaluate the Safety and Anti-hypertensive Efficacy of Losartan 50 mg / Hydrochlorothiazide (HCTZ) 12.5 mg Combination in Patients With Mild to Moderate Essential Hypertension
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to evaluate the safety and antihypertensive efficacy of MK-0954A (Losartan 50 mg / Hydrochlorothiazide (HCTZ) 12.5 mg) in participants with mild to moderate essential hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Losartan 50 mg / HCTZ 12.5 mg | Losartan 50 mg / HCTZ 12.5 mg tablet once daily for 12 weeks |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2011-09-09
- Last updated
- 2024-05-22
- Results posted
- 2011-11-22
Source: ClinicalTrials.gov record NCT01431508. Inclusion in this directory is not an endorsement.